Compugen Ltd.
(TEL Aviv Stock Exchange : CGEN)

( )
CGEN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
REGNRegeneron Pharmaceuticals, Inc. -1.30%722.372.6%$744.92m
AMGNAmgen, Inc. -0.83%229.031.4%$603.47m
BIIBBiogen, Inc. -1.67%257.891.8%$570.38m
MRNAModerna, Inc. -4.66%119.320.0%$562.46m
GILDGilead Sciences, Inc. -1.02%64.291.0%$544.46m
VRTXVertex Pharmaceuticals, Inc. -1.14%295.231.9%$425.03m
ILMNIllumina, Inc. -3.07%206.183.2%$398.21m
SNSSSunesis Pharmaceuticals, Inc. 1.24%4.070.7%$284.51m
SAVACassava Sciences, Inc. -5.71%39.930.0%$178.84m
BNTXBioNTech SE -2.05%134.710.0%$107.16m
TECHBio-Techne Corp. -4.23%296.004.5%$96.50m
BMRNBioMarin Pharmaceutical, Inc. -3.64%88.154.2%$92.43m
PRTAProthena Corp. Plc -3.98%56.2413.8%$76.06m
CRSPCRISPR Therapeutics AG -5.53%61.650.6%$73.89m
NVAXNovavax, Inc. -9.85%16.3075.6%$71.67m

Company Profile

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.